Tretinoin
DrugBank ID: DB00755
Summary
| Metric | Value |
|---|---|
| Total Predictions | 53 |
| KG+DL (Dual Validated) | 1 |
| DL Only | 49 |
| KG Only | 3 |
Predictions
| Indication | Score | Source |
|---|---|---|
| acne (disease) | 0.9993 | KG+DL |
| rheumatoid nodulosis | 0.9984 | DL |
| rheumatoid factor-positive polyarticular juvenile idiopathic arthritis | 0.9982 | DL |
| juvenile idiopathic arthritis | 0.9980 | DL |
| juvenile chronic polyarthritis | 0.9978 | DL |
| spondyloarthropathy, susceptibility to | 0.9971 | DL |
| juvenile arthritis due to defect in LACC1 | 0.9955 | DL |
| osteoarthritis | 0.9944 | DL |
| pseudoachondroplasia | 0.9935 | DL |
| acromesomelic dysplasia, Hunter-Thompson type | 0.9930 | DL |
| Quinquaud's folliculitis decalvans | 0.9930 | DL |
| hereditary hypotrichosis with recurrent skin vesicles | 0.9928 | DL |
| osteoarthritis susceptibility | 0.9927 | DL |
| alopecia antibody deficiency | 0.9923 | DL |
| alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome | 0.9920 | DL |
| alopecia mucinosa | 0.9915 | DL |
| alopecia areata | 0.9914 | DL |
| telogen effluvium | 0.9914 | DL |
| brachyolmia-amelogenesis imperfecta syndrome | 0.9907 | DL |
| myosclerosis | 0.9900 | DL |
| brachyolmia | 0.9891 | DL |
| WHIM syndrome | 0.9878 | DL |
| acute lymphoblastic/lymphocytic leukemia | 0.9876 | DL |
| chronic lymphocytic leukemia/small lymphocytic lymphoma with immunoglobulin heavy chain variable-region gene somatic hypermutation | 0.9875 | DL |
| pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma | 0.9875 | DL |
| atrichia with papular lesions | 0.9856 | DL |
| arthropathy | 0.9846 | DL |
| zinc, elevated plasma | 0.9783 | DL |
| chondrocalcinosis | 0.9778 | DL |
| ankylosing spondylitis | 0.9777 | DL |
| avascular necrosis of femoral head, primary | 0.9752 | DL |
| spondyloarthropathy | 0.9730 | DL |
| rheumatoid vasculitis | 0.9718 | DL |
| hyaline fibromatosis syndrome | 0.9701 | DL |
| Stickler syndrome, type I, nonsyndromic ocular | 0.9700 | DL |
| heparin cofactor 2 deficiency | 0.9696 | DL |
| combined immunodeficiency due to moesin deficiency | 0.9670 | DL |
| spondyloepimetaphyseal dysplasia, Handigodu type | 0.9661 | DL |
| platyspondylic dysplasia, Torrance type | 0.9656 | DL |
| transient arthritis | 0.9655 | DL |
| spondylometaphyseal dysplasia, Schmidt type | 0.9655 | DL |
| vertebral disease | 0.9652 | DL |
| hemophilic arthropathy | 0.9650 | DL |
| negative rheumatoid factor polyarthritis | 0.9650 | DL |
| Czech dysplasia, metatarsal type | 0.9650 | DL |
| factor 5 excess with spontaneous thrombosis | 0.9640 | DL |
| megaepiphyseal dwarfism | 0.9634 | DL |
| mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis | 0.9624 | DL |
| inflammatory spondylopathy | 0.9623 | DL |
| spondyloperipheral dysplasia-short ulna syndrome | 0.9615 | DL |
Showing top 50 of 53 predictions.
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.